🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMarketplace & ListingsNew vendor application — April 2026 verification cycle Page 2

New vendor application — April 2026 verification cycle

Admin Mon, Jan 29, 2024 at 9:20 PM 128 replies 58,574 viewsPage 2 of 20
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Jan 29, 2024 at 11:21 PM#6

One concrete data point for the thread. Red flags, in rough order of how much they should worry you: no verifiable address, no batch numbers, prices far under market, vendor-commissioned tests only, pressure toward irreversible payment, and shipping with no temperature control.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: Jan 30, 2024 at 5:21 AM
48 18SleepFixSam, PurityPaulOR, MaxMetOK and 45 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Jan 30, 2024 at 12:08 AM#7

A narrower follow-up, since the general answer is now clear:

What a vetting checklist should actually contain, as opposed to a list of things that are easy to fake?

47 17GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 44 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Jan 30, 2024 at 12:55 AM#8
wendy_avl said:
Red flags, in rough order of how much they should worry you: no verifiable address, no batch numbers, prices far under market, vendor-commissioned…

Coming at wendy_avl’s question from a different direction. The pattern that distinguishes a bad batch from an exit is behaviour rather than product. A bad batch comes with communication, a reshipment offer and a batch number. An exit comes with slower replies, pressure toward less reversible payment methods, sudden discounting, and the same reassurance repeated without any new information. The product tells you less than the correspondence does.

Last edited: Jan 30, 2024 at 6:55 AM
46 16tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 43 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 30, 2024 at 1:42 AM#9

OP back with an update, since a thread like this is useless without one.

Went back through my own correspondence with an earlier supplier and the warning signs were all there in the replies, weeks before the quality changed. I was reading the product and not the behaviour.

45 15BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 42 others
Reply Quote Save Share Report
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Jan 30, 2024 at 5:28 AM#10
roxy_nash said:
The pattern that distinguishes a bad batch from an exit is behaviour rather than product.

Right, and one flattering data point from a group buy is not consistency. Consistency means separate batches, separately commissioned, over months.

43 18gary_naperville, sean_dublin, hannah_MT and 40 others
Reply Quote Save Share Report

Similar Threads

Price comparison: compounded semaglutide — June 202622 replies
Telehealth provider directory — updated quarterly5 replies
Group buy discussion — is it worth organizing?3 replies
Bacteriostatic water sourcing guide — verified suppliers3 replies
Compounded semaglutide price tracker — updated weekly19 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register